Lifeboat Foundation

The first time it happened, I was in a high school physics class. Suddenly, I couldn’t read half of the board. A crack zig-zagged through my vision, obscuring my teacher’s notes. “Huh,” I thought. “This can’t be good.”

My classmate walked me to the school nurse, who called my mom. Pain rippled from the back of my neck to my forehead. I’d had headaches before, but not like this. “Ah, your first migraine,” Mom said. “Welcome to the club.”

For nearly a billion people worldwide, migraine attacks disrupt work, vacation and school. They can be triggered by stress, weather changes, hormone shifts, missed meals or sleep changes — in other words, just about anything. These reoccurring headaches often spur pain on one side of the head. They can last a few hours or a few days, and they can cause nausea along with sensitivity to noises and light.

A new CRISPR-based gene-editing tool has been developed which could lead to better treatments for patients with genetic disorders. The tool is an enzyme, AsCas12f, which has been modified to offer the same effectiveness but at one-third the size of the Cas9 enzyme commonly used for gene editing. The compact size means that more of it can be packed into carrier viruses and delivered into living cells, making it more efficient.

Researchers created a library of possible AsCas12f mutations and then combined selected ones to engineer an AsCas12f enzyme with 10 times more editing ability than the original unmutated type. This engineered AsCas12f has already been successfully tested in mice and has the potential to be used for new, more effective treatments for patients in the future.

By now you have probably heard of CRISPR, the gene-editing tool which enables researchers to replace and alter segments of DNA. Like genetic tailors, scientists have been experimenting with “snipping away” the genes that make mosquitoes malaria carriers, altering food crops to be more nutritious and delicious, and in recent years begun human trials to overcome some of the most challenging diseases and genetic disorders.

Eating a type of dietary fiber called chitin evoked an immune response in mice that was linked to better metabolic health.

This is a significant development that brings hope to the one billion individuals with obesity worldwide. Researchers led by Director C. Justin LEE from the Center for Cognition and Sociality (CCS) within the Institute for Basic Science (IBS) have discovered new insights into the regulation of fat metabolism. The focus of their study lies within the star-shaped non-neuronal cells in the brain, known as ‘astrocytes’. Furthermore, the group announced successful animal experiments using the newly developed drug ‘KDS2010’, which allowed the mice to successfully achieve weight loss without resorting to dietary restrictions.

The complex balance between food intake and energy expenditure is overseen by the hypothalamus in the brain. While it has been known that the neurons in the lateral hypothalamus are connected to fat tissue and are involved in fat metabolism, their exact role in fat metabolism regulation has remained a mystery. The researchers discovered a cluster of neurons in the hypothalamus that specifically express the receptor for the inhibitory neurotransmitter ‘GABA (Gamma-Aminobutyric Acid)’. This cluster has been found to be associated with the α5 subunit of the GABAA receptor and was hence named the GABRA5 cluster.

In a diet-induced obese mouse model, the researchers observed significant slowing in the pacemaker firing of the GABRA5 neurons. Researchers continued with the study by attempting to inhibit the activity of these GABRA5 neurons using chemogenetic methods. This in turn caused a reduction in heat production (energy consumption) in the brown fat tissue, leading to fat accumulation and weight gain. On the other hand, when the GABRA5 neurons in the hypothalamus were activated, the mice were able to achieve a successful weight reduction. This suggests that the GABRA5 neurons may act as a switch for weight regulation.

New research hints at a few ways fatty foods affect cells in the brain, a finding that could help explain the link between a high-fat diet and impaired memory – especially as we age.

The Ohio State University study in cell cultures found the omega-3 fatty acid DHA may help protect the brain from an unhealthy diet’s effects by curbing fat-induced inflammation at the cellular source.

Separate experiments using brain tissue from aging mice showed a high-fat diet may lead specific brain cells to overdo cell-signaling management in a way that interferes with the creation of new memories.

Augmented reality (AR) technology has long fascinated both the scientific community and the general public, remaining a staple of modern science fiction for decades.

In the pursuit of advanced AR assistants—ones that can guide people through intricate surgeries or everyday food preparation, for example—a research team from NYU Tandon School of Engineering has introduced Augmented Reality Guidance and User-Modeling System, or ARGUS.

An interactive visual analytics tool, ARGUS is engineered to support the development of intelligent AR assistants that can run on devices like Microsoft HoloLens 2 or MagicLeap. It enables developers to collect and analyze data, model how people perform tasks, and find and fix problems in the AR assistants they are building.

The animal looked and barked like a dog—albeit one with long, pointed, foxlike ears—but it also climbed bushes, a behavior more typical of the local Pampas fox, and it refused common dog food, preferring to eat rats.

Caretakers began to wonder if it might be a hybrid—a mixture of domestic dog and some local wild canid. They contacted geneticists Thales Renato Ochotorena de Freitas from the Universidade Federal do Rio Grande do Sul and Rafael Kretschmer from the Universidade Federal de Pelotas who, last month, published a study confirming the animal was the world’s first documented fox-dog. The finding excited and intrigued experts in animal genetics.

“What a strange hybrid beast!” wrote Roland Kays, a biologist with North Carolina State University and the North Carolina Museum of Natural Sciences, on X (formerly Twitter), alongside a photo of the creature and link to the study.

Dopamine seems to be having a moment in the zeitgeist. You may have read about it in the news, seen viral social media posts about “dopamine hacking,” or listened to podcasts about how to harness what this molecule is doing in your brain to improve your mood and productivity. However, recent neuroscience research suggests that popular strategies to control dopamine are based on an overly narrow view of how it functions.

Dopamine is one of the brain’s neurotransmitters — tiny molecules that act as messengers between neurons. It is known for its role in tracking your reaction to rewards such as food, sex, money, or answering a question correctly. There are many kinds of dopamine neurons located in the uppermost region of the brainstem that manufacture and release dopamine throughout the brain. Whether neuron type affects the function of the dopamine it produces has been an open question.

Recently published research reports a relationship between neuron type and dopamine function, and one type of dopamine neuron has an unexpected function that will likely reshape how scientists, clinicians, and the public understand this neurotransmitter.

With the rapid-paced rise of AI in everyday life, nothing, not even the traditional farmer, is untouched by the technology.

A survey of the latest generation of farm tools provides a taste of just how far modern farming has come.

The Ecorobotix, a seven-foot-wide GPS-assisted “table on wheels” as some have described it, is a solar battery-powered unit that roams crop fields and destroys weeds with pinpoint precision. It boasts a 95% efficiency rate, with virtually no waste.